ES492310A0 - Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas - Google Patents

Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas

Info

Publication number
ES492310A0
ES492310A0 ES492310A ES492310A ES492310A0 ES 492310 A0 ES492310 A0 ES 492310A0 ES 492310 A ES492310 A ES 492310A ES 492310 A ES492310 A ES 492310A ES 492310 A0 ES492310 A0 ES 492310A0
Authority
ES
Spain
Prior art keywords
hydroxy
substituted
pirrolin
dionas
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES492310A
Other languages
English (en)
Other versions
ES8105283A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES492310A0 publication Critical patent/ES492310A0/es
Publication of ES8105283A1 publication Critical patent/ES8105283A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/456—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
ES492310A 1979-06-11 1980-06-10 Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas Expired ES8105283A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/047,413 US4256758A (en) 1979-06-11 1979-06-11 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

Publications (2)

Publication Number Publication Date
ES492310A0 true ES492310A0 (es) 1981-05-16
ES8105283A1 ES8105283A1 (es) 1981-05-16

Family

ID=21948829

Family Applications (1)

Application Number Title Priority Date Filing Date
ES492310A Expired ES8105283A1 (es) 1979-06-11 1980-06-10 Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas

Country Status (10)

Country Link
US (1) US4256758A (es)
EP (1) EP0021228B1 (es)
JP (1) JPS562962A (es)
AT (1) ATE1501T1 (es)
DE (1) DE3060801D1 (es)
DK (1) DK249680A (es)
ES (1) ES8105283A1 (es)
GR (1) GR68727B (es)
IE (1) IE49902B1 (es)
PT (1) PT71368B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428959A (en) * 1980-04-04 1984-01-31 Merck & Co., Inc. 4-Alkylsubstituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
JPS5816528U (ja) * 1981-07-25 1983-02-01 三菱重工業株式会社 液位計
US4605663A (en) * 1984-05-01 1986-08-12 Merck & Co., Inc. Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, for treatment of grey matter edema
US4596821A (en) * 1984-05-01 1986-06-24 Merck & Co., Inc. Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones
US4634717A (en) * 1984-05-01 1987-01-06 Merck & Co., Inc. Substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema
US4604403A (en) * 1984-05-01 1986-08-05 Merck & Co., Inc. Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema
US4605664A (en) * 1984-05-01 1986-08-12 Merck & Co., Inc. Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treatment of grey matter edema
ES2070914T3 (es) * 1988-10-29 1995-06-16 Cadbury Schweppes Plc Agente tensioactivo.
US6353128B1 (en) * 1996-12-03 2002-03-05 Eli Lilly And Company Phenyl acetamides as sPLA2 inhibitors
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
CA2592118C (en) 2004-12-23 2015-11-17 Deciphera Pharmaceuticals, Llc Urea derivatives as enzyme modulators
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
US8143293B2 (en) 2007-04-20 2012-03-27 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
MX2011004535A (es) 2008-10-29 2011-11-18 Deciphera Pharmaceuticals Llc Ciclopropanamidas y analogos que exhiben actividades anti-cancer y anti-proliferativas.
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
KR102258469B1 (ko) 2012-12-17 2021-05-31 패리온 사이언스 인코퍼레이티드 불충분한 점막 수화에 의해 유발되는 질환의 치료에 유용한 클로로-피라진 카르복스아미드 유도체
WO2014099673A1 (en) 2012-12-17 2014-06-26 Parion Sciences, Inc. 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
DE102013213217A1 (de) 2013-07-05 2015-01-08 Bayerische Motoren Werke Aktiengesellschaft Schließbaugruppe für einen Gepäckkoffer
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
WO2017100268A1 (en) * 2015-12-07 2017-06-15 Wake Forest University Health Sciences Combinations for the treatment of kidney stones
CN107805209B (zh) * 2016-09-09 2020-11-10 中国石化扬子石油化工有限公司 一种对二乙酰苯酰胺化制备2-(4-氨基甲酰基甲基-苯基)-乙酰胺的方法
WO2021030405A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
KR20220045189A (ko) 2019-08-12 2022-04-12 데시페라 파마슈티칼스, 엘엘씨. 위장관 기질 종양을 치료하는 방법
EP4084778B1 (en) 2019-12-30 2023-11-01 Deciphera Pharmaceuticals, LLC Amorphous kinase inhibitor formulations and methods of use thereof
KR20220123058A (ko) 2019-12-30 2022-09-05 데시페라 파마슈티칼스, 엘엘씨. 1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의 조성물
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184475A (en) * 1961-09-15 1965-05-18 Monsanto Co Maleimides, maleamides and fumaramides
US3183245A (en) * 1963-01-04 1965-05-11 Parke Davis & Co Process for the production of alpha-methyl-alpha-phenyl-beta-ethylsuccinimide
DE1445664A1 (de) * 1963-07-04 1969-11-27 Klinke Desitin Werk Verfahren zur Herstellung von alpha,alpha-disubstituierten Succinimiden
CH445487A (de) * 1963-08-05 1967-10-31 Calanda Stiftung Verfahren zur Darstellung cyclischer Imide
US3340263A (en) * 1964-02-14 1967-09-05 Ciba Geigy Corp Amino-pyrroles
US3317390A (en) * 1965-07-27 1967-05-02 American Cyanamid Co Compositions having cns depressant activity

Also Published As

Publication number Publication date
DK249680A (da) 1980-12-12
ES8105283A1 (es) 1981-05-16
JPS562962A (en) 1981-01-13
EP0021228A1 (en) 1981-01-07
GR68727B (es) 1982-02-10
IE49902B1 (en) 1986-01-08
ATE1501T1 (de) 1982-09-15
PT71368A (en) 1980-07-01
DE3060801D1 (en) 1982-10-28
PT71368B (en) 1981-10-21
US4256758A (en) 1981-03-17
EP0021228B1 (en) 1982-09-01
IE801178L (en) 1980-12-11

Similar Documents

Publication Publication Date Title
ES492310A0 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
ES494933A0 (es) Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa.
MX159208A (es) Procedimiento para la fabricacion de suturas quirurgicas mejoradas
NO160761C (no) Kirurgisk, absorberbar sutur, samt fremgangsmaate for densfremstillig.
ES2021411B3 (es) Proceso para la preparacion de (2,2) paraciclofano.
ES499363A0 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
ES2023165B3 (es) Procedimiento para la preparacion de t-alquil-taralquilperoxidos.
ES2017485B3 (es) Proceso para la preparacion de alfa-n-(hipoxantin-9il)pentiloxi-carbonil-arginina.
ES2018532B3 (es) Procedimiento para la preparacion de compuestos carbonilicos.
ES1004869Y (es) Atadura para la fijacion de sarmientos.
ES520847A0 (es) Procedimiento para la preparacion de 1,2,4-triazol-1-il-propionitrilos.
ES520201A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina.
MX12003A (es) Procedimiento para la preparacion de composicionesherbicidas.
ES2023395B3 (es) Procedimiento para el condicionamiento de desechos secos, bionocivos.
MX15981A (es) Procedimiento para la preparacion de compuestos hidrosolubles de ftalocianina.
AR240312A1 (es) Compuesto de 2-carboximetil-azetidina, procedimiento de preparacion y composicon para esterilizacion de anteras.
ES524706A0 (es) Procedimiento para la preparacion de n-(2-piridil)-(1,4-dimetil-5-(4-clorobenzoil))-2-pirrolacetamida.
ES492796A0 (es) Procedimiento para la preparacion de 4-oxa-6-aza-6(fenil-es-piro)(2.4)heptan-5,7-dionas
MX13201A (es) Procedimiento para la preparacion de 4-aril-5carbamoil-1,4-dihidro-piridinas.
ES1007991Y (es) Protesis para anastomosis vascular.
ES1008390Y (es) Horma perfeccionada para la fabricacion de calzado.
ES550849A0 (es) Procedimiento para la oxidacion de ciclohexano.
PL212775A1 (pl) Zestaw do chirurgicznego leczenia zlaman kosci,zwlaszcza zuchwy

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000403